Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients

Proteomics

Volumn 13, Issue 17, 2013, Pages 2670-2681

  Krisp, Christoph ^a,b   Jacobsen, Frank ^a   Mckay, Matthew J ^b   Molloy, Mark P ^b   Steinstraesser, Lars ^a   Wolters, Dirk A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Biomedicine; Diabetes mellitus; MudPIT; Wound healing

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; COLLAGEN; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PROTEIN S 100; PROTEIN S 100A9; PROTEOME; SERINE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ACUTE DISEASE; ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC DISEASE; CLINICAL ARTICLE; COMPUTER PROGRAM; DIABETIC FOOT; DIABETIC PATIENT; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TISSUE INJURY; TISSUE NECROSIS; WESTERN BLOTTING; WOUND; WOUND HEALING; ZYMOGRAPHY;

BIOMEDICINE; DIABETES MELLITUS; MUDPIT; WOUND HEALING;

ADULT; AGED; ANNEXIN A5; APOPTOSIS; CALGRANULIN A; CALGRANULIN B; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; EXUDATES AND TRANSUDATES; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOME; PROTEOMICS; SKIN; SKIN TRANSPLANTATION; TANDEM MASS SPECTROMETRY; WOUND HEALING; YOUNG ADULT;

EID: 84883304996     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200502     Document Type: Article

References (42)

1. Smola, H., Thiekötter, G., Fusenig, N., Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J. Cell Biol. 1993, 122, 417-429.
2. Bauer, S. M., Bauer, R. J., Velazquez, O. C., Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc. Endovascular Surg. 2005, 39, 293-306.
3. Hackam, D. J., Ford, H. R., Cellular, biochemical, and clinical aspects of wound healing. Surg. Infect. 2002, 3, 23-35.
4. Eming, S. A., Hubbell, J. A., Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp. Dermatol. 2011, 20, 605-613.
5. Liu, Y., Min, D., Bolton, T., Nubé, V. et al., Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009, 32, 117-119.
6. Madlener, M., Parks, W. C., Werner, S., Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res. 1998, 242, 201-210.
7. Muller, M., Trocme, C., Lardy, B., Morel, F. et al., Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabetic Med. 2008, 25, 419-426.
8. Bowler, P. G., Davies, B. J., The microbiology of infected and noninfected leg ulcers. Int. J. Dermatol. 1999, 38, 573-578.
9. Snyder, R. J., Treatment of nonhealing ulcers with allografts. Clin. Dermatol. 2005, 23, 388-395.
10. Bach, J. P., Rinn, B., Meyer, B., Dodel, R., Bacher, M., Role of MIF in inflammation and tumorigenesis. Oncology 2008, 75, 127-133.
11. Stadelmann, W. K., Digenis, A. G., Tobin, G. R., Physiology and healing dynamics of chronic cutaneous wounds. Am. J. Surg. 1998, 176, 26S-38S.
12. Blakytny, R., Jude, E., The molecular biology of chronic wounds and delayed healing in diabetes. Diabetic Med. 2006, 23, 594-608.
13. Amano, S., Akutsu, N., Ogura, Y., Nishiyama, T., Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. Br. J. Dermatol. 2004, 151, 961-970.
14. Eming, S. A., Koch, M., Krieger, A., Brachvogel, B. et al., Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J. Proteome Res. 2010, 9, 4758-4766.
15. Rayment, E. A., Dargaville, T. R., Shooter, G. K., George, G. A., Upton, Z., Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 2008, 29, 1785-1795.
16. Labler, L. M. D., Rancan, M. M. D., Mica, L. M. D., Harter, L. P. et al., Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds. J. Trauma 2009, 66, 749-757.
17. Harding, K. G., Morris, H. L., Patel, G. K., Science, medicine, and the future - healing chronic wounds. B M J 2002, 324, 160-163.
18. Kilpadi, D. V., Stechmiller, J. K., Childress, B., Cowan, L. et al., Composition of wound fluid from pressure ulcers treated with negative pressure wound therapy using VAC (R) therapy in home health or extended care patients: a pilot study. Wounds 2006, 18, 119-128.
19. Rennekampff, H.-O., Hansbrough, J. F., Kiessig, V., Doré, C. et al., Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J. Surg. Res. 2000, 93, 41-54.
20. Thomay, A. A., Daley, J. M., Sabo, E., Worth, P. J. et al., Disruption of interleukin-1 signaling improves the quality of wound healing. Am. J. Pathol. 2009, 174, 2129-2136.
21. Lansdown, A. B. G., Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen. 2002, 10, 271-285.
22. Donato, R., Perspectives in S-100 protein biology. Cell Calcium 1991, 12, 713-726.
23. Washburn, M. P., Wolters, D. A., Yates, J. R., Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
24. Wolters, D. A., Washburn, M. P., Yates, J. R., 3rd, An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 2001, 73, 5683-5690.
25. Goyette, J., Yan, W. X., Yamen, E., Chung, Y. M. et al., Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture. J. Immunol. 2009, 183, 593-603.
26. Zhang, Z., Huang, L., Zhao, W., Rigas, B., Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res. 2010, 70, 2379-2388.
27. Brownlee, M., The Pathobiology of diabetic complications. Diabetes 2005, 54, 1615-1625.
28. Vlassara, H., Palace, M. R., Diabetes and advanced glycation endproducts. J. Intern. Med. 2002, 251, 87-101.
29. Kokkola, R., Andersson, Å., Mullins, G., Östberg, T. et al., RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 2005, 61, 1-9.
30. Moor, A. N., Vachon, D. J., Gould, L. J., Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen. 2009, 17, 832-839.
31. Nedeau, A. E., Gallagher, K. A., Liu, Z.-J., Velazquez, O. C., Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis. J. Vasc. Surg. 2011, 54, 1430-1438.
32. Ikari, Y., Fujikawa, K., Yee, K. O., Schwartz, S. M., α1-Proteinase inhibitor, α1-antichymotrypsin, or α2-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. J. Biol. Chem. 2000, 275, 12799-12805.
33. Di Colandrea, T., Wang, L., Wille, J., D/'Armiento, J., Chada, K. K., Epidermal expression of collagenase delays wound-healing in transgenic mice. J. Invest. Dermatol. 1998, 111, 1029-1033.
34. Mogues, T., Etzerodt, M., Hall, C., Engelich, G. et al., Tetranectin binds to the kringle 1-4 form of angiostatin and modifies its functional activity. J. Biomed. Biotechnol. 2004, 2004, 73-78.
35. Sreenivasan, A., Anti-angiogenesis is anti-actin. J. Cell Biol. 2004, 166, 6-7.
36. Leffers, H., Nielsen, M. S., Andersen, A. H., Honore, B. et al., Identification of 2 human Rho GDP-dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. Exp. Cell Res. 1993, 209, 165-174.
37. Latijnhouwers, M. A., Bergers, M., Van Bergen, B. H., Spruijt, K. I. et al., Tenascin expression during wound healing in human skin. J. Pathol. 1996, 178, 30-35.
38. Anderson, K. S., Wong, J., Polyak, K., Aronzon, D., Enerbäck, C., Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br. J. Dermatol. 2009, 160, 325-332.
39. El-Rachkidy, R. G., Young, H. S., Griffiths, C. E. M., Camp, R. D. R., Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. J. Invest. Dermatol. 2008, 128, 2219-2224.
40. Quarta, S., Vidalino, L., Turato, C., Ruvoletto, M. et al., SERPINB3 induces epithelial-mesenchymal transition. J. Pathol. 2010, 221, 343-356.
41. Xu, J., Zhang, X., Pelayo, R., Monestier, M. et al., Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15, 1318-1321.
42. Badiavas, E., Falanga, V., Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol. 2003, 139, 510-516.